About this trial
The purpose of this research study is to develop a protocol using a fully wearable, portable lower-limb exoskeleton for improving leg and walking function in people with movement disorders. The study investigates the effects of wearing the device during a set of experiments including leg stretching, treadmill walking and overground walking in muscle activity, joint motion, and gait performance. The goal is to develop an effective lower-limb strategy to restore lost leg function (e.g., range of motion) and gait ability, and improve quality of life in people with movement deficits following a neurological disorder.
Eligibility criteria
Qualifiers
Veteran individuals with spasticity due to spinal cord injury (SCI) at least 6 months post SCI
Capable of providing informed consent and reporting age, gender, and neurological condition
Neurologically stable (>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction
Disqualifiers
Participants should not experience another neurological disorder except their primary diagnosed neurological condition (spinal cord injury)
Participants should not be pregnant
Participants should weigh less than 300 lbs
Participants should not have experienced signs of hip/knee pain during the past 2-3 weeks that limits mobility (i.e., reaching, walking, lifting, etc.)
Trial design
Treatments tested in this trial
- Wearable Robotic Exoskeleton
Treatment groups
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
Syracuse University
Collaborator